TOKYO, July 12, 2016 (GLOBE NEWSWIRE) -- FRONTEO, Inc. (“FRONTEO”) (Nasdaq:FTEO) (TSE:2158), a leading provider of international litigation support and big-data analysis services, and FRONTEO Healthcare, Inc. (“FRONTEO Healthcare”), a wholly-owned FRONTEO subsidiary providing medical data analysis solutions, will exhibit at the International Modern Hospital Show 2016 at Tokyo Big Sight from July 13th through the 15th. At the event, the companies will showcase their healthcare solutions using artificial intelligence (“AI”) technology, including a system to mitigate patients’ risk of falling as well as a system to provide for the early diagnosis of potential mental disorders.
The system uses AI technology to detect signs of physical weakness through the analysis of text data contained in electronic medical records and day-to-day examination records. Since FRONTEO and FRONTEO Healthcare started co-developing the AI-based system with NTT Medical Center Tokyo in March 2015, researchers have made major progress on its prediction accuracy. Today, the system is yielding increasingly accurate results with its evaluation methodology monitoring for the risk of falling, as compared to other evaluation methods. The companies will display applications that will soon be used in a real-world setting.
At the event, FRONTEO will also present a seminar on the development status of medical equipment utilized for the qualitative evaluation of mental disorders, a project commissioned by the Japan Agency for Medical Research and Development (AMED), as well as on the improvement of quality control and patient feedback analysis.
Details of FRONTEO’s exhibition booth and seminar are as follows:
Exhibition booth
| Date: | Wednesday, July 13th through Friday, July 15th from 10:00 a.m. to 5 p.m. |
| Location: | Nursing and Rehabilitation Zone, East Hall, Tokyo Big Sight |
| Booth: | A-10 |
Seminar
| Date: | Thursday, July 14th, 11:00 a.m. to 11:50 a.m |
| Location: | 6F, convention building, Tokyo Big Sight |
| Speaker: | Hideki Takeda |
| Director, FRONTEO, Director and Chief Technology Officer, | |
| Behavior Informatics Laboratories, Director, FRONTEO Healthcare | |
| Masahisa Nakao | |
| Nurse, healthcare safety management office, NTT Medical Center Tokyo | |
| Title: | “Current Status of AI-Based Analysis of Electronic Medical Records and Prediction of In-Hospital Patients’ Risk of Falling” |
About FRONTEO, Inc.
FRONTEO, Inc. (“FRONTEO”) (Nasdaq:FTEO) (TSE:2158) supports the analysis of big data based on behavior informatics by utilizing its technology, "KIBIT". FRONTEO's KIBIT technology is driven by FRONTEO AI based on knowledge acquired through its litigation support services. The KIBIT incorporates experts' tacit knowledge, including their experiences and intuitions, and utilizes that knowledge for big data analysis. FRONTEO continues to expand its business operations by applying KIBIT to new fields such as healthcare and marketing. FRONTEO was founded in 2003 as a provider of e-discovery and international litigation support services. These services include the preservation, investigation and analysis of evidence materials contained in electronic data, and computer forensic investigation. FRONTEO provides e-discovery and litigation support by making full use of its data analysis platform, "Lit i View®", and its Predictive Coding technology adapted to Asian languages. The company name was changed from UBIC, Inc. to FRONTEO, Inc. as of July 1, 2016.
For more information about FRONTEO, contact usinfo@fronteo.com or visit http://www.fronteo.com/global/
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the amount of data that FRONTEO expects to manage this year and the potential uses for FRONTEO's new service in intellectual property-related litigation, contain forward-looking statements. FRONTEO may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about FRONTEO's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: FRONTEO's goals and strategies; FRONTEO's expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, FRONTEO's services; FRONTEO's expectations regarding keeping and strengthening its relationships with customers; FRONTEO's plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where FRONTEO provides solutions and services. Further information regarding these and other risks is included in FRONTEO's reports filed with, or furnished to the Securities and Exchange Commission. FRONTEO does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and FRONTEO undertakes no duty to update such information, except as required under applicable law.